001     285813
005     20260401143002.0
024 7 _ |a 10.1080/17469899.2025.2563196
|2 doi
024 7 _ |a 1746-9899
|2 ISSN
024 7 _ |a 1746-9902
|2 ISSN
037 _ _ |a DZNE-2026-00349
082 _ _ |a 610
100 1 _ |a Yu-Wai-Man, Patrick
|b 0
245 _ _ |a Idebenone as a treatment for Leber hereditary optic neuropathy: A plain language summary of the LEROS study publication
260 _ _ |a Abingdon
|c 2025
|b Taylor & Francis Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1775046347_19920
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Newman, Nancy J.
|b 1
700 1 _ |a Poincenot, Lissa
|b 2
700 1 _ |a Ferguson, James
|b 3
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 4
|e Last author
|u dzne
773 _ _ |a 10.1080/17469899.2025.2563196
|g Vol. 20, no. 6, p. 333 - 350
|0 PERI:(DE-600)2261704-8
|n 6
|p 333 - 350
|t Expert review of ophthalmology
|v 20
|y 2025
|x 1746-9899
787 0 _ |a Yu-Wai-Man, Patrick et.al.
|d Maryland Heights, MO : Elsevier, 2024
|i RelatedTo
|0 DZNE-2024-00303
|r
|t Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
856 4 _ |u https://pub.dzne.de/record/285813/files/DZNE-2026-00349.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/285813/files/DZNE-2026-00349.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2810704
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-11-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-11-05
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EXPERT REV OPHTHALMO : 2022
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-11-05
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-11-05
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21